GRDN · Guardian Pharmacy Services, Inc. · Webcasts, Transcripts & Audio
$49.52
+0.14 (+0.28%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$3.14B
Shares
63.35M
Volume · Nov 13
339.13K
Avg daily vol (3M)
534.7K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Guardian Pharmacy Services, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Guardian Pharmacy Services, Inc. (GRDN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-18
Guardian Pharmacy Services, Inc. (GRDN) November 18, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-11-05
Guardian Pharmacy Services, Inc. (GRDN) Q3 2026 Earnings Call Transcript
Confident tone
Financial Growth and Profitability
Macro and Policy Risks
Acquisitions and Geographic Expansion
Revenue
$371.07M
▼ 1.7% YoY Diluted EPS
$0.29
▲ 93.3% YoY Gross margin
23.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-15
Guardian Pharmacy Services, Inc. (GRDN) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-06
Guardian Pharmacy Services, Inc. (GRDN) Q2 2026 Earnings Call Transcript
Revenue
$351.77M
▲ 2.2% YoY Gross margin
22.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
Guardian Pharmacy Services, Inc. (GRDN) Q1 2026 Earnings Call Transcript
Positive tone
IRA transition and drug pricing impact
Gross profit and EBITDA results
M&A pipeline and national accounts
Revenue
$336.60M
▲ 2.2% YoY Gross margin
22.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-11
Guardian Pharmacy Services, Inc. (GRDN) Q4 2025 Earnings Call Transcript
Confident tone
Inflation Reduction Act (IRA) Impact
Vaccine Clinics
Clinical Value and Interventions
Revenue
$397.62M*
▲ 17.4% YoY Gross margin
21.5%
Rev · 7q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-10
Guardian Pharmacy Services, Inc. (GRDN) Q3 2025 Earnings Call Transcript
Positive tone
Acquisitions and Greenfields
Margin Pressure from New Pharmacies
Revenue and EBITDA Growth
Revenue
$377.43M
▲ 20% YoY Diluted EPS
$0.15
Gross margin
19.8%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-11
Guardian Pharmacy Services, Inc. (GRDN) Q2 2025 Earnings Call Transcript
Confident tone
Acquisitions and Greenfields
Growth and Guidance Raise
Margin Pressure from M&A Integration
Revenue
$344.33M
▲ 14.8% YoY Gross margin
19.8%
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Guardian Pharmacy Services, Inc. (GRDN) Q1 2025 Earnings Call Transcript
Confident tone
Revenue and EBITDA Growth
Acquisitions and Integration
Tariff Impact Assessment
Revenue
$329.31M
▲ 19.6% YoY Gross margin
19.5%
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-26
Guardian Pharmacy Services, Inc. (GRDN) Q4 2024 Earnings Call Transcript
Confident tone
Revenue and EBITDA growth
M&A and greenfield expansion
Inflation Reduction Act risk
Revenue
$338.57M*
Gross margin
19.8%
Rev · 4q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Guardian Pharmacy Services, Inc. (GRDN) Q3 2024 Earnings Call
Revenue
$314.39M
▲ 19.7% YoY Gross margin
19.4%
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–11 of 11 webcasts
Key facts
CIK
1802255
CUSIP
40145W101
13F (30d)
137 filings
133 filers
Visit website
Investor relations